These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6578368)

  • 1. Mitochondrial toxicity of 2,5-diaziridinyl-3,6-bis-(carboethoxyamino)-1,4-benzoquinone.
    Oberc-Greenwood MA; Smith BH; Cooke C; Ellis JR; Kornblith PL; McKeever PE
    J Natl Cancer Inst; 1983 Oct; 71(4):725-33. PubMed ID: 6578368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II and pharmacokinetic study of aziridinylbenzoquinone [2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] in high-grade gliomas.
    Curt GA; Kelley JA; Kufta CV; Smith BH; Kornblith PL; Young RC; Collins JM
    Cancer Res; 1983 Dec; 43(12 Pt 1):6102-5. PubMed ID: 6640549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lack of correlation between toxicity and free radical formation of two diaziridinyl benzoquinones.
    Lea JS; Garner HJ; Butler J; Hoey BM; Ward TH
    Biochem Pharmacol; 1988 May; 37(10):2023-5. PubMed ID: 2837220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential cytotoxicity of diaziquone toward Chinese hamster ovary cells under hypoxic and aerobic exposure conditions.
    O'Brien PJ; Kaul HK; Rauth AM
    Cancer Res; 1990 Mar; 50(5):1516-20. PubMed ID: 2302714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical activation of AZQ [3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone] to its free radical species.
    Gutierrez PL; Friedman RD; Bachur NR
    Cancer Treat Rep; 1982 Feb; 66(2):339-42. PubMed ID: 6275990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (diaziquone) in isolated nuclei from human cells.
    Szmigiero L; Kohn KW
    Cancer Res; 1984 Oct; 44(10):4453-7. PubMed ID: 6467205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of DNA strand breaks and cross-links by 2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone in Chinese hamster ovary cells.
    King CL; Hittelman WN; Loo TL
    Cancer Res; 1984 Dec; 44(12 Pt 1):5634-7. PubMed ID: 6498824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ).
    King CL; Wong SK; Loo TL
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):261-4. PubMed ID: 6538490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of a new antitumor agent, AZQ, to penetrate into cerebrospinal fluid.
    Gormley PE; Wood JH; Poplack DG
    Pharmacology; 1981; 22(3):196-8. PubMed ID: 7208602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reduction of anti-tumour diaziridinyl benzoquinones.
    Butler J; Hoey BM; Lea JS
    Biochim Biophys Acta; 1987 Aug; 925(2):144-9. PubMed ID: 3040109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sister chromatid exchange induction by diaziquone in human and mouse lymphocytes following both in vivo and in vitro exposures.
    Kligerman AD; Erexson GL; Bryant MF
    Cancer Res; 1988 Jan; 48(1):27-31. PubMed ID: 3334997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans.
    Schilsky RL; Kelley JA; Ihde DC; Howser DM; Cordes RS; Young RC
    Cancer Res; 1982 Apr; 42(4):1582-6. PubMed ID: 7060028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular pharmacology in murine and human leukemic cell lines of diaziquone (NSC 182986).
    Egorin MJ; Fox BM; Spiegel JF; Gutierrez PL; Friedman RD; Bachur NR
    Cancer Res; 1985 Mar; 45(3):992-9. PubMed ID: 3971389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diaziquone-induced cytotoxicity in isolated rat hepatocytes.
    Silva JM; O'Brien PJ
    Cancer Res; 1989 Oct; 49(20):5550-4. PubMed ID: 2790779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacologic fate of 2,5-diaziridinyl-3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ NSC-182986) by intracarotid or intravenous administration in beagles.
    Feun LG; Savaraj N; Lu K; Guo Z; Raulston LG; Benjamin RS; Fields WS; Loo TL
    J Neurooncol; 1983; 1(3):219-24. PubMed ID: 6678971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical species.
    Gutierrez PL; Egorin MJ; Fox BM; Friedman R; Bachur NR
    Biochem Pharmacol; 1985 May; 34(9):1449-55. PubMed ID: 3994758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumors.
    Feun LG; Yung WK; Leavens ME; Burgess MA; Obbens EA; Bedikian AY; Savaraj N; Stewart DJ; Benjamin RS; Fields WS
    J Neurooncol; 1984; 2(1):13-7. PubMed ID: 6088722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebral penetration and tissue distribution of 2,5-diaziridinyl 3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ, NSC-182986).
    Savaraj N; Lu K; Feun LG; Leavens ME; Stewart D; Burgess MA; Benjamin RS; Loo TL
    J Neurooncol; 1983; 1(1):15-9. PubMed ID: 6678302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA strand scission and cross-linking by diaziridinylbenzoquinone (diaziquone) in human cells and relation to cell killing.
    Szmigiero L; Erickson LC; Ewig RA; Kohn KW
    Cancer Res; 1984 Oct; 44(10):4447-52. PubMed ID: 6467204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of diaziquone free radicals on the in vitro activity of diaziquone.
    Nguyen B; Biswal S; Gutierrez PL
    Xenobiotica; 1988 May; 18(5):593-602. PubMed ID: 2840783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.